Dr. Lyora Aharonov is an experienced project manager, and expert in biological research with 15+ years of extensive hands-on and management experience in academic and industrial R&D. Prior to joining NurExone, Lyora served as a project manager at Adicet Bio Israel, a pre-clinical stage biotechnology company designing and developing cutting-edge immunotherapies for cancer. Lyora recently led the development of a new technology for high-throughput diagnosis of SARS-CoV-2 at Barcode Diagnostics. Lyora holds a Ph.D. in biotechnology from the Technion, Israel Institute of Technology.